tradingkey.logo
tradingkey.logo
Search

Citius Oncology Inc

CTOR
Add to Watchlist
0.562USD
-0.016-2.77%
Close 07-24 16:00ETQuotes delayed by 15 min
47.67MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Citius Pharmaceuticals Inc
74.82%
Armistice Capital LLC
6.33%
10XYZ Holdings LP
2.24%
Bartushak (Jaime)
0.93%
Vanguard Capital Management, LLC
0.61%
Other
15.07%
Shareholders
Shareholders
Proportion
Citius Pharmaceuticals Inc
74.82%
Armistice Capital LLC
6.33%
10XYZ Holdings LP
2.24%
Bartushak (Jaime)
0.93%
Vanguard Capital Management, LLC
0.61%
Other
15.07%
Shareholder Types
Shareholders
Proportion
Corporation
77.06%
Hedge Fund
6.37%
Individual Investor
0.96%
Investment Advisor
0.81%
Investment Advisor/Hedge Fund
0.35%
Family Office
0.12%
Pension Fund
0.12%
Venture Capital
0.08%
Bank and Trust
0.02%
Other
14.10%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
42
7.13M
8.08%
-5.78M
2025Q4
46
8.69M
7.64%
--
2025Q3
48
8.69M
8.51%
+8.12M
2025Q2
45
642.07K
10.03%
+122.48K
2025Q1
46
519.59K
10.53%
-7.01M
2024Q4
47
615.46K
10.52%
+143.23K
2024Q3
43
472.23K
10.87%
-3.52M
2024Q2
41
3.99M
111.28%
-380.05K
2024Q1
40
4.37M
77.19%
-2.53M
2023Q4
34
6.07M
68.43%
+555.45K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Citius Pharmaceuticals Inc
66.05M
74.82%
--
--
Dec 10, 2025
Armistice Capital LLC
5.58M
6.33%
-2.09M
-27.25%
Dec 31, 2025
10XYZ Holdings LP
1.98M
2.24%
-65.05K
-3.18%
Aug 13, 2024
Bartushak (Jaime)
825.00K
0.93%
+825.00K
--
Sep 19, 2025
Geode Capital Management, L.L.C.
220.05K
0.25%
+52.88K
+31.63%
Dec 31, 2025
Independent Financial Partners
87.42K
0.1%
+54.21K
+163.21%
Dec 31, 2025
OMERS Administration Corporation
104.50K
0.12%
+104.50K
--
Dec 31, 2025
XTX Markets LLC
73.99K
0.08%
-52.89K
-41.69%
Dec 31, 2025
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.